Teikoku Pharma USA Inc - Company Review
Teikoku Pharma USA Inc - Company ReviewSummary
Teikoku Pharma USA Inc (Teikoku Pharma), a subsidiary of Teikoku Seiyaku Co Ltd is a pharmaceutical company that develops products in the CNS, pain management and oncology. The company’s products include lidoderm and versatis. Its lidoderm products comprise prescription, topical, hydrogel patch approved drugs for post-herpetic neuralgia (PHN) and provides analgesia directly to the affected nerves. Teikoku Pharma’s versatis is used for the management of neuropathic pain associated with previous herpes zoster infection. The company also offers non-alcohol docetaxel injection that is used for the treatment of non-small cell lung cancer, breast cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. Teikoku Pharma is headquartered in San Jose, California, the US.
This comprehensive company report of Teikoku Pharma USA Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.